Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04665323 · ClinicalTrials.gov registry record
An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.
A clinical trial, sponsored by Ipsen.
- Completed
- Registry status
- 411
- Enrollment target
NCT04665323 is a clinical trial that has completed, run by Ipsen. The registered enrollment target is 411 participants.
The verdict
NCT04665323 has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 411 participants
- Enrollment target
Study Summary
The FOP burden of illness (BoI) survey aims to assess the impact of the burden of FOP on patients and their families. The study is being conducted online and available for residents in Argentina, Brazil, Canada, France, Germany, Italy, Japan, Mexico, Poland, Russia, South Korea, Spain, Sweden, the US, and the UK.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 411 participants |
| Start Date | 2021-01-18 |
| Est. Completion | 2021-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04665323
The ClinicalTrials.gov registry entry for NCT04665323 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ipsen, which has 85 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04665323 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04665323 about?
NCT04665323 is a clinical study titled "An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.". The FOP burden of illness (BoI) survey aims to assess the impact of the burden of FOP on patients and their families. The study is being conducted online and available for residents in Argentina, Brazil, Canada, France, Germany, Italy, Japan, Mexico, Poland, Russia, South Korea, Spain, Sweden, the U...
What is the current status of trial NCT04665323?
This trial is currently completed. The enrollment target is 411 participants. The study started on 2021-01-18. Estimated completion is 2021-04-30.
Who is sponsoring clinical trial NCT04665323?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.